Embla Medical hf Past Earnings Performance

Past criteria checks 4/6

Embla Medical hf's earnings have been declining at an average annual rate of -5.1%, while the Medical Equipment industry saw earnings declining at 5.9% annually. Revenues have been growing at an average rate of 4.2% per year. Embla Medical hf's return on equity is 7.8%, and it has net margins of 7.1%.

Key information

-5.1%

Earnings growth rate

-5.3%

EPS growth rate

Medical Equipment Industry Growth	-9.5%
Revenue growth rate	4.2%
Return on equity	7.8%
Net Margin	7.1%
Next Earnings Update	23 Jul 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Embla Medical hf makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

LSE:0FIW Revenue, expenses and earnings (USD Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Mar 24	804	57	368	38
31 Dec 23	786	58	360	38
30 Sep 23	766	52	353	37
30 Jun 23	750	45	354	36
31 Mar 23	730	43	345	34
31 Dec 22	719	43	339	34
30 Sep 22	715	47	339	34
30 Jun 22	719	57	331	33
31 Mar 22	728	62	331	34
31 Dec 21	719	64	328	32
30 Sep 21	701	50	323	32
30 Jun 21	692	48	318	31
31 Mar 21	637	11	308	31
31 Dec 20	630	6	307	31
30 Sep 20	639	20	303	30
30 Jun 20	635	19	308	30
31 Mar 20	680	59	311	31
31 Dec 19	686	66	308	31
30 Sep 19	675	83	296	31
30 Jun 19	652	85	284	31
31 Mar 19	631	83	274	31
31 Dec 18	613	80	265	31
30 Sep 18	599	69	259	31
30 Jun 18	593	64	254	31
31 Mar 18	579	58	252	30
31 Dec 17	569	58	245	29
30 Sep 17	553	49	246	29
30 Jun 17	543	51	239	27
31 Mar 17	538	52	240	25
31 Dec 16	521	51	233	23
30 Sep 16	507	49	227	21
30 Jun 16	495	50	219	20
31 Mar 16	483	51	209	19
31 Dec 15	483	51	208	18
30 Sep 15	488	54	209	18
30 Jun 15	497	55	213	18
31 Mar 15	502	57	214	19
31 Dec 14	509	59	218	19
30 Sep 14	509	58	217	20
30 Jun 14	487	55	207	20
31 Mar 14	460	46	199	21
31 Dec 13	436	40	189	22
30 Sep 13	406	35	178	22
30 Jun 13	400	33	177	23

Quality Earnings: 0FIW has high quality earnings.

Growing Profit Margin: 0FIW's current net profit margins (7.1%) are higher than last year (6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 0FIW's earnings have declined by 5.1% per year over the past 5 years.

Accelerating Growth: 0FIW's earnings growth over the past year (31%) exceeds its 5-year average (-5.1% per year).

Earnings vs Industry: 0FIW earnings growth over the past year (31%) exceeded the Medical Equipment industry 17.9%.

Embla Medical hf Past Earnings Performance

Past criteria checks 4/6

Key information

Recent past performance updates

First quarter 2024 earnings released: EPS: US$0.019 (vs US$0.024 in 1Q 2023)

Full year 2023 earnings released: EPS: US$0.14 (vs US$0.10 in FY 2022)

Össur hf. to Report Q1, 2024 Results on Apr 23, 2024

First quarter 2023 earnings released: EPS: US$0.024 (vs US$0.022 in 1Q 2022)

Full year 2022 earnings released

Össur hf. to Report Q1, 2023 Results on Apr 25, 2023

Recent updates

First quarter 2024 earnings released: EPS: US$0.019 (vs US$0.024 in 1Q 2023)

Less than half of directors are independent

Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee

Less than half of directors are independent

Investor sentiment improves as stock rises 16%

Full year 2023 earnings released: EPS: US$0.14 (vs US$0.10 in FY 2022)

Össur hf. Provides Earnings Guidance for the Year 2024

Less than half of directors are independent

Össur hf. to Report Q1, 2024 Results on Apr 23, 2024

Össur hf., Annual General Meeting, Mar 12, 2025

Less than half of directors are independent

Össur hf. Reaffirms Financial Guidance for the Year 2023

Less than half of directors are independent

Össur hf. Announces Executive Changes

First quarter 2023 earnings released: EPS: US$0.024 (vs US$0.022 in 1Q 2022)

Less than half of directors are independent

Less than half of directors are independent

Össur hf. Provides Earnings Guidance for the Year 2023

Full year 2022 earnings released

Less than half of directors are independent

Össur hf. to Report Q1, 2023 Results on Apr 25, 2023

Less than half of directors are independent

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: US$0.016 (vs US$0.041 in 3Q 2021)

Less than half of directors are independent

Össur hf. (CPSE:OSSR) acquired Naked Prosthetics.

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: US$0.034 (vs US$0.046 in 2Q 2021)

Össur hf. Revises Earnings Guidance for the Year 2022

Össur hf. Reports Preliminary Earnings Results for the Second Quarter and First Half of 2022

Less than half of directors are independent

Össur Appoints Gudny Arna Sveinsdottir as Chief Financial Officer, Effective September 1, 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Össur Hf. Announces New R&D Leadership

Less than half of directors are independent

Össur Launches New POWER KNEE

Össur hf. Announces Sales Guidance for the Full Year 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Össur Hf. Announces Earnings Guidance for the Full Year 2021

First quarter 2021 earnings released: EPS US$0.027 (vs US$0.017 in 1Q 2020)

Össur Hf. Provides Financial Guidance for the Full Year 2021

Vice Chairman Kristján Ragnarsson has left the company

Full year 2020 earnings released: EPS US$0.015 (vs US$0.16 in FY 2019)

Revenue misses expectations

Össur hf., Annual General Meeting, Mar 08, 2022

Laboratoires Innothera S.A.S completed the acquisition of Gibaud SAS from Össur hf. (CPSE:OSSR).

Össur Hf. Withdraw Its Financial Guidance for 2020

Revenue & Expenses BreakdownBeta

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Revenue & Expenses Breakdown
Beta